[Pharmacology of anxiolytics and their therapeutic use].
Tada
Koji
K
Department of Neuropsychiatry, Nihon University, School of Medicine.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000145:classification / Q000494:pharmacology* / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001569:Benzodiazepines; D003864:Depression, Chemical; D004195:Disease Models, Animal; D006801:Humans; D054833:Isoindoles; D009638:Norepinephrine / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use; D011985:Receptors, Serotonin / Q000187:drug effects; D044263:Receptors, Serotonin, 5-HT1; D012701:Serotonin / Q000378:metabolism; D017366:Serotonin Receptor Agonists / Q000494:pharmacology* / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D054833:Isoindoles; D010879:Piperazines; D011743:Pyrimidines; D011985:Receptors, Serotonin; D044263:Receptors, Serotonin, 5-HT1; D017366:Serotonin Receptor Agonists; D001569:Benzodiazepines; C055267:tandospirone; D012701:Serotonin; D009638:Norepinephrine